Back to Crohns Disease And Colitis
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00195715

NCT00195715
Completed Phase 3 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You must have already successfully completed one of two specific earlier clinical trials (called M02-404 or M04-691) to be eligible for this study
  • You have been diagnosed with Crohn's disease
  • You are willing and able to agree to take part and sign a consent form

Who may not be able to join:

  • You have been diagnosed with ulcerative colitis
  • You are currently pregnant or breastfeeding
  • You have had a previous infection with listeria (a type of food-borne bacteria) or have tuberculosis that has not been treated
  • You have a history of cancer, unless it was a skin cancer that was successfully treated or a very early-stage cervical condition (called carcinoma-in-situ) that was successfully treated

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 3
Sponsor
Abbott
Registry
clinicaltrials_gov
Start date
1 September 2004
Est. completion
1 March 2006

Where this trial is recruiting

🇦🇺 Australia 🇧🇪 Belgium 🇨🇦 Canada 🇩🇰 Denmark 🇫🇷 France 🇩🇪 Germany 🇭🇺 Hungary 🇮🇹 Italy 🇳🇱 Netherlands 🇵🇱 Poland 🇿🇦 South Africa 🇪🇸 Spain 🇸🇪 Sweden 🇬🇧 United Kingdom 🇺🇸 United States

4 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Percentage of Subjects Achieving Clinical Remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov